Epibatidine and its analogues as nicotinic acetylcholine receptor agonist: An update

Natural Product Research

Volumn 20, Issue 5, 2006, Pages 497-505

  Yogeeswari, Perumal ^a   Sriram, Dharmarajan ^a   Bal, Tanushree Ratan ^a   Thirumurugan, Rathinasabapathy ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Alkaloid; Analgesics; Epibatidine; Nicotinic acetylcholine receptor

Indexed keywords

2 AMINO 5 PYRIMIDINYL EPIBATIDINE DERIVATIVE; 7 N ACETYL EPIBATIDINE DERIVATIVE; 7 N METHYL EPIBATIDINE DERIVATIVE; ALKALOID DERIVATIVE; ANTINOCICEPTIVE AGENT; DICHLORO EPIBATIDINE DERIVATIVE; EPIBATIDINE; EPIBOXIDINE; HOMOEPIBATIDINE; MORPHINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; OPIATE RECEPTOR; PUMILIOTOXIN; SUXAMETHONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINOCICEPTION; ARTICLE; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; DRUG CONFORMATION; DRUG EFFECT; DRUG ISOLATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FROG; LOW DRUG DOSE; MOUSE; NONHUMAN; RECEPTOR AFFINITY; STRUCTURE ANALYSIS;

ANALGESICS, NON-NARCOTIC; ANIMALS; ANURA; BICYCLO COMPOUNDS, HETEROCYCLIC; NICOTINIC AGONISTS; PAIN; PHYTOTHERAPY; PYRIDINES; RECEPTORS, NICOTINIC; SKIN; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; ANURA; DENDROBATIDAE; EPIPEDOBATES TRICOLOR;

EID: 33646414827     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786410600604583     Document Type: Article

References (37)

1. Spande, TE and Garraffo, HM and Edwards, MW and Yeh, HJC and Pannell, L and Daly, JW. (1992) J. Am. Chem. Soc., 114, pp. 3475.
2. Broka, CA. (1993) Tetrahedron Lett., 34, pp. 3251.
3. Fletcher, SR and Baker, R and Chamber, MS and Hobbsh, SC and Mitchell, PJ. (1994) J. Org. Chem., 59, pp. 1771.
4. Badio, B and Daly, JW. (1994) Mol. Pharmacol., 45, pp. 563.
5. Daly, JW and Tokuyama, T and Fuzuwara, T and Highet, RJ and Karle, IL. (1980) J. Am. Chem. Soc., 102, pp. 830.
6. Corey, EJ and Loh, TE and Rao, AS and Daley, DC and Sarsharl, S. (1993) J. Org. Chem., 58, pp. 5600.
7. Huang, DF and Shen, TY. (1993) Tetrahedron Lett., 34, pp. 4477.
8. Clayton, SC and Regan, AC. (1993) Tetrahedron Lett., 34, pp. 7493.
9. Broka, CA. (1993) Tetrahedron Lett., 34, pp. 3251.
10. Chen, Z and Trudell, ML. (1996) Chem. Rev., 96, pp. 1179.
11. Szantay, C and Balogh, KZ and Szantay, C, Jr.(1995) The Alkaloids. San Diego: Academic Press.
12. Aoyagi, S and Tanaka, R and Masaichi, N and Kibayashi, C. (1998) J. Org. Chem., 63, pp. 8397.
13. Sirosama, NS and Johnson, CR. (1998) Tetrahedron Lett., 39, pp. 2059.
14. Bannon, AW and Gunther, KL and Idecker, MW. (1995) Pharmacol. Biochem. Behav., 51, pp. 693.
15. Qian, C and Li, T and Shen, TY and Garahan, LL and Eckman, J and Biftu, T. (1993) Eur. J. Pharmacol., 250, pp. 13.
16. Sullivan, JP and Bannon, AW. (1996) CNS Drug Rev., 2, pp. 21.
17. Bonhaus, DW and Bley, KR and Broka, CA and Fontana, DJ and Leung, E and Lewis, R and Shieh, A and Wong, EHF. (1995) J. Pharmacol. Exp. Ther., 272, pp. 1199.
18. Suvillan, JP and Decker, MW and Brioni, JD and Roberts, DD and Anderson, AW and Bannon, AW and Kang, CH and Adams, P and Kaplan, MP and Buckley, MJ and Gopalkrishnan, M and Williams, M and Americ, SP. (1994) J. Pharmacol. Exp. Ther., 271, pp. 624.
19. Elgoyhen, AB and Velter, DE and Katz, E and Rothlin, CV and Heinemann, SF and Boulter, J. (2001) Proc. Natl. Acad. Sci. USA, 98, pp. 3501.
20. Corringer, PJ and Le Novere, N and Changeux, JP. (2000) Annu. Rev. Pharmacol. Toxicol., 40, pp. 431.
21. Quick, M and Polonskaya, Y and Gillespie, A and Jakoweck, M and Lloydl, GK and Langstan, JW. (2000) J. Comp. Neurol., 425, pp. 58.
22. Suvillan, JP and Anneric, SP. (1996) Neuropharmacol., 35, pp. 725.
23. Papke, RL and Fiebe, CM and De Moulton, BA and Thinschmidt, JS and Quintana, R and Meyer, EM. (1995) Soc. Neurosci., 21, pp. 607.
24. Lembeck, F and Gamse, R. (1999) Arch. Pharmacol., 359, pp. 378.
25. Li, T and Qian, C and Eckman, J and Huang, DF and Shen, TY. (1993) Bioorg. Med. Chem. Lett., 3, pp. 2759.
26. Badio, B and Garraffo, HM and Plummer, CV and Padgett, WL and Daly, JW. (1997) Eur. J. Pharmacol., 321, pp. 189.
27. Seerden, JG and Tulp, MTM and Scheeren, HW and Kruse, CG. (1998) Bioorg. Med. Chem., 6, pp. 2103.
28. Spang, JE and Bertrand, S and Westera, G and Patt, JT and Schubiger, PA and Bertrand, D. (2000) Chem. Biol., 7, pp. 545.
29. Radl, S and Hezky, P and Hafner, W and Budesinsky, M and Hejnova, L. (2000) Bioorg. Med. Chem. Lett., 10, pp. 55.
30. Carroll, FI and Liang, F and Navarro, HA and Brieaddy, LE and Abraham, P and Damaj, MI and Martin, BR. (2001) J. Med. Chem., 44, pp. 2229.
31. Avolas, M and Parker, MJ and Maddox, FN and Carroll, FI and Leutje, CW. (2002) J. Pharmacol. Exp. Ther., 302, pp. 1246.
32. Carroll, FI and Lee, JR and Navarro, HA and Ma, W and Brieaddy, LE and Abraham, P and Damaj, MI and Martin, BR. (2002) J. Med. Chem., 45, pp. 4755.
33. Cheng, J and Zhang, C and Stevens, ED and Izenwasser, S and Wade, D and Chen, S and Paul, D and Trudell, ML. (2002) J. Med. Chem., 45, pp. 3041.
34. Che, C and Petit, G and Hibert, FK and Bertrand, S and Bertrand, D and Grutter, T and Goeldner, M. (2003) Bioorg. Med. Chem. Lett., 13, pp. 1001.
35. Wei, ZL and Petukhov, PA and Xiao, Y and Tuckmantel, W and George, C and Kellar, KJ and Kozkowski, AP. (2003) J. Med. Chem., 46, pp. 921.
36. Barlocco, D and Cignarella, G and Tondi, D and Vianello, P and Villa, S and Bartolini, A and Ghelardini, C and Galeotti, N and Anderson, DJ and Kuntzweiler, TA and Colombo, D and Toma, L. (1998) J. Med. Chem., 41, pp. 674.
37. Tonder, JE and Hansen, JB and Begtrup, M and Petterson, I and Rimvalll, K and Christensen, B and Ehrbar, U and Olesen, PH. (1999) J. Med. Chem., 42, pp. 4970.